Literature DB >> 16226320

Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus.

Yohannes Berhane1, Jody D Berry, Charlene Ranadheera, Peter Marszal, Brigitte Nicolas, Xin Yuan, Markus Czub, Hana Weingartl.   

Abstract

Nipah virus, a zoonotic paramyxovirus which emerged recently was chemically inactivated using binary ethylenimine (BEI). The inactivated virus was concentrated and purified by sucrose gradient centrifugation. The gradient fractions were examined by electron microscopy and Western immunoblot, and gradient fraction containing mainly Nipah matrix (M) and nucleocapsid (N) proteins was used for immunizing BALB/c mice to generate hybridomas. Screening of the resultant hybridoma clones identified five strongly positive clones producing IgG monoclonal antibodies (mAbs) reactive to the Nipah virus antigen. The protein specificity of these mAbs was determined by Western immunoblot using Nipah virus and recombinant Nipah virus proteins expressed in mammalian cells. Four mAbs reacted with Nipah N protein and one reacted with Nipah M protein. None of the mAbs neutralized Nipah virus infectivity in vitro. However, all mAbs recognized Nipah virus in ELISA and immunofluorescence assay. F45G2 mAb was most suitable for immunohistochemistry on long term formalin-fixed Nipah virus infected swine tissues. Three of the anti-nucleocapsid mAbs (F45G2, F45G3 and F45G6) showed cross-reactivity with closely related Hendra virus N protein in both immunofluorescence and Western Immunoblot assays. Two of the mAbs were specific for the Nipah virus only, F45G4 (anti-N) and F45G5 (anti-M), and could be used in the primary identification of Nipah virus. The use of these immunoreagents to develop new diagnostic assays is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226320     DOI: 10.1016/j.jviromet.2005.09.005

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  13 in total

1.  Recombinant nipah virus vaccines protect pigs against challenge.

Authors:  Hana M Weingartl; Yohannes Berhane; Jeff L Caswell; Sheena Loosmore; Jean-Christophe Audonnet; James A Roth; Markus Czub
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA.

Authors:  Cheng-Feng Chiang; Michael K Lo; Paul A Rota; Christina F Spiropoulou; Pierre E Rollin
Journal:  Virol J       Date:  2010-06-03       Impact factor: 4.099

3.  Nipah virus entry and egress from polarized epithelial cells.

Authors:  Boris Lamp; Erik Dietzel; Larissa Kolesnikova; Lucie Sauerhering; Stephanie Erbar; Hana Weingartl; Andrea Maisner
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

4.  Nipah virus infection: current scenario.

Authors:  D D Kulkarni; C Tosh; G Venkatesh; D Senthil Kumar
Journal:  Indian J Virol       Date:  2013-11-07

5.  Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.

Authors:  Kerstin Fischer; Sandra Diederich; Greg Smith; Sven Reiche; Vinicius Pinho Dos Reis; Eileen Stroh; Martin H Groschup; Hana M Weingartl; Anne Balkema-Buschmann
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

6.  Pathogenicity of Nipah henipavirus Bangladesh in a swine host.

Authors:  S B Kasloff; A Leung; B S Pickering; G Smith; E Moffat; B Collignon; C Embury-Hyatt; D Kobasa; H M Weingartl
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

7.  Experimental inoculation study indicates swine as a potential host for Hendra virus.

Authors:  Mingyi Li; Carissa Embury-Hyatt; Hana M Weingartl
Journal:  Vet Res       Date:  2010-01-20       Impact factor: 3.683

8.  The YPLGVG sequence of the Nipah virus matrix protein is required for budding.

Authors:  Jared R Patch; Ziying Han; Sarah E McCarthy; Lianying Yan; Lin-Fa Wang; Ronald N Harty; Christopher C Broder
Journal:  Virol J       Date:  2008-11-10       Impact factor: 4.099

9.  ANP32B is a nuclear target of henipavirus M proteins.

Authors:  Anja Bauer; Sebastian Neumann; Axel Karger; Ann-Kristin Henning; Andrea Maisner; Boris Lamp; Erik Dietzel; Linda Kwasnitschka; Anne Balkema-Buschmann; Günther M Keil; Stefan Finke
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

10.  Establishment of an RNA polymerase II-driven reverse genetics system for Nipah virus strains from Malaysia and Bangladesh.

Authors:  Bryan D Griffin; Anders Leung; Mable Chan; Bryce M Warner; Charlene Ranadheera; Kevin Tierney; Jonathan Audet; Kathy L Frost; David Safronetz; Carissa Embury-Hyatt; Stephanie A Booth; Darwyn Kobasa
Journal:  Sci Rep       Date:  2019-08-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.